Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008;3(5):364-365.
doi: 10.1159/000175098.

Trastuzumab Improves the Efficacy of Chemotherapy in Breast Cancer Treatment beyond Progression

GBG GERMAN BREAST GROUP; Christina Pirvulescu, Mathias Uhlig, Gunter von Minckwitz

Trastuzumab Improves the Efficacy of Chemotherapy in Breast Cancer Treatment beyond Progression

GBG GERMAN BREAST GROUP et al. Breast Care (Basel). 2008.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Time to disease progression. Product-limit survival estimates with number of subjects at risk. X = Capecitabine, XH = X + trastuzumab.
Fig. 2
Fig. 2
Overall survival. Product-limit survival estimates with number of subjects at risk. X = Capecitabine, XH = X + trastuzumab.
See this image and copyright information in PMC

References

    1. von Minckwitz G, Zielinski C, Maartense E, Vogel P, Schmidt M, Maass N, Cufer T, de Jongh FE, Kaufmann M, Nekljudova V, Loibl S. Capecitabine vs. capecitabine + trastuzumab in patients with HER2-positive metastatic breast cancer progressing during trastuzumab treatment: The TBP phase III study (GBG 26/BIG 3-05) J Clin Oncol. 2008;26(Suppl) abstr.1025.